A detailed history of Fmr LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Fmr LLC holds 1,132,061 shares of ZLAB stock, worth $23.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,132,061
Previous 1,404,417 19.39%
Holding current value
$23.5 Million
Previous $22.5 Million 12.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$13.72 - $21.55 $3.74 Million - $5.87 Million
-272,356 Reduced 19.39%
1,132,061 $19.6 Million
Q1 2024

May 13, 2024

BUY
$15.95 - $26.8 $2.67 Million - $4.49 Million
167,490 Added 13.54%
1,404,417 $22.5 Million
Q4 2023

Feb 13, 2024

SELL
$22.97 - $30.58 $718,386 - $956,389
-31,275 Reduced 2.47%
1,236,927 $33.8 Million
Q3 2023

Nov 13, 2023

SELL
$22.72 - $31.49 $16 Million - $22.2 Million
-705,751 Reduced 35.75%
1,268,202 $30.8 Million
Q2 2023

Aug 11, 2023

SELL
$25.3 - $39.67 $27.8 Million - $43.6 Million
-1,100,116 Reduced 35.79%
1,973,953 $54.7 Million
Q1 2023

May 11, 2023

SELL
$30.21 - $48.1 $39.8 Million - $63.3 Million
-1,316,638 Reduced 29.99%
3,074,069 $102 Million
Q4 2022

Feb 13, 2023

SELL
$22.28 - $38.71 $7.05 Million - $12.2 Million
-316,334 Reduced 6.72%
4,390,707 $135 Million
Q3 2022

Nov 10, 2022

BUY
$34.2 - $51.69 $44.5 Million - $67.3 Million
1,301,187 Added 38.2%
4,707,041 $161 Million
Q2 2022

Aug 12, 2022

SELL
$23.14 - $49.68 $26.6 Million - $57.2 Million
-1,150,975 Reduced 25.26%
3,405,854 $118 Million
Q1 2022

May 13, 2022

BUY
$27.77 - $64.4 $41.4 Million - $95.9 Million
1,489,812 Added 48.58%
4,556,829 $200 Million
Q4 2021

Feb 14, 2022

SELL
$54.9 - $105.21 $39.1 Million - $74.9 Million
-711,755 Reduced 18.84%
3,067,017 $193 Million
Q3 2021

Nov 15, 2021

SELL
$105.0 - $178.37 $66.9 Million - $114 Million
-636,933 Reduced 14.42%
3,778,772 $398 Million
Q2 2021

Aug 13, 2021

BUY
$125.11 - $180.0 $552 Million - $795 Million
4,415,705 New
4,415,705 $782 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.03B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.